Rezultati - Keith T. Flaherty

Refine Results
  1. 1
    Chemotherapy and Targeted Therapy Combinations in Advanced Melanoma

    Chemotherapy and Targeted Therapy Combinations in Advanced Melanoma od Keith T. Flaherty

    Izdano 2006
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    MAP kinase signaling and inhibition in melanoma

    MAP kinase signaling and inhibition in melanoma od Ryan J. Sullivan, Keith T. Flaherty

    Izdano 2012
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance

    BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance od Ryan J. Sullivan, Keith T. Flaherty

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    BRAF, a target in melanoma

    BRAF, a target in melanoma od Keith T. Flaherty, Grant A. McArthur

    Izdano 2010
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Integrating BRAF/MEK inhibitors into combination therapy for melanoma

    Integrating BRAF/MEK inhibitors into combination therapy for melanoma od Keiran S.M. Smalley, Keith T. Flaherty

    Izdano 2009
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Targeting the RAS pathway in melanoma

    Targeting the RAS pathway in melanoma od Zhenyu Ji, Keith T. Flaherty, Hensin Tsao

    Izdano 2011
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways

    Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways od Xue Bai, David E. Fisher, Keith T. Flaherty

    Izdano 2019
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    YAP in MAPK pathway targeted therapy resistance

    YAP in MAPK pathway targeted therapy resistance od Keith T. Flaherty, Jennifer A. Wargo, Trever G. Bivona

    Izdano 2015
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy

    Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy od Jennifer A. Lo, David E. Fisher, Keith T. Flaherty

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    The Intersection of Immune-Directed and Molecularly Targeted Therapy in Advanced Melanoma: Where We Have Been, Are, and Will Be

    The Intersection of Immune-Directed and Molecularly Targeted Therapy in Advanced Melanoma: Where We Have Been, Are, and Will Be od Ryan J. Sullivan, Patricia LoRusso, Keith T. Flaherty

    Izdano 2013
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Mutation-driven drug development in melanoma

    Mutation-driven drug development in melanoma od Keith T. Flaherty, F. Stephen Hodi, Boris C. Bastian

    Izdano 2010
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Universes Collide: Combining Immunotherapy with Targeted Therapy for Cancer

    Universes Collide: Combining Immunotherapy with Targeted Therapy for Cancer od Jennifer A. Wargo, Zachary A. Cooper, Keith T. Flaherty

    Izdano 2014
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Melanoma: New Insights and New Therapies

    Melanoma: New Insights and New Therapies od Vasiliki Nikolaou, Alexander Stratigos, Keith T. Flaherty, Hensin Tsao

    Izdano 2012
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Mechanisms of resistance to immune checkpoint inhibitors

    Mechanisms of resistance to immune checkpoint inhibitors od Russell W. Jenkins, David A. Barbie, Keith T. Flaherty

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    The Conundrum of Genetic “Drivers” in Benign Conditions

    The Conundrum of Genetic “Drivers” in Benign Conditions od Shumei Kato, Scott M. Lippman, Keith T. Flaherty, Razelle Kurzrock

    Izdano 2016
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Precision medicine for cancer with next-generation functional diagnostics

    Precision medicine for cancer with next-generation functional diagnostics od Adam A. Friedman, Anthony Letai, David E. Fisher, Keith T. Flaherty

    Izdano 2015
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma

    Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma od Neel M. Fofaria, Dennie T. Frederick, Ryan J. Sullivan, Keith T. Flaherty, Sanjay Srivastava

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    p53 Rescue through HDM2 Antagonism Suppresses Melanoma Growth and Potentiates MEK Inhibition

    p53 Rescue through HDM2 Antagonism Suppresses Melanoma Growth and Potentiates MEK Inhibition od Zhenyu Ji, Ching Ni Njauw, Michael Taylor, Victor Neel, Keith T. Flaherty, Hensin Tsao

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    BRAF Inhibition Generates a Host–Tumor Niche that Mediates Therapeutic Escape

    BRAF Inhibition Generates a Host–Tumor Niche that Mediates Therapeutic Escape od Inna V. Fedorenko, Jennifer A. Wargo, Keith T. Flaherty, Jane L. Messina, Keiran S.M. Smalley

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    A Melanoma Molecular Disease Model

    A Melanoma Molecular Disease Model od Smruti J. Vidwans, Keith T. Flaherty, David E. Fisher, Jay M. Tenenbaum, Michael Travers, Jeff Shrager

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: